Condition
Chronic Coronary Occlusion
Total Trials
6
Recruiting
0
Active
0
Completed
6
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
67%
4 of 6 completed with results
Key Signals
4 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed6
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT03265769Not ApplicableCompletedPrimary
Femoral or Radial Approach in Coronary Chronic Total Occlusion
NCT01205776Not ApplicableCompletedPrimary
EXCEL Clinical Trial
NCT01249027Completed
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study
NCT01086228Completed
XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan
NCT01120379CompletedPrimary
XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)
NCT01205789CompletedPrimary
EXCEL Clinical Trial (Universal Registry)
Showing all 6 trials